Join us on the latest episode! Our Guest: Bill Peters, CEO at On Target Laboratories.What you'll get out of this episode:Innovative Imaging for Surgery – On Target Laboratories enables surgeons to see cancer at the cellular level using near-infrared imaging.Cytalux for Lung & Ovarian Cancer – Their FDA-approved drug, Cytalux, helps identify tumors in real-time, improving surgical outcomes.Surgeon-Driven Development – Continuous feedback from surgeons drives research, refining the technology for broader applications.Future of Cancer Surgery – With ongoing clinical trials, On Target Laboratories aims to expand its imaging technology to new indications.Industry Engagement – The company actively participates in key medical conferences, connecting with experts to advance cancer care.To Learn More About Our Guest And Their Company:Guest LinkedIn https://www.linkedin.com/in/bill-peters-749a332a/Company LinkedIn https://www.linkedin.com/company/on-target-laboratories-inc/ Website http://www.ontargetlabs.com Our sponsor for this episode are:Sage Growth Partners https://sage-growth.com/BioBreakthroughs is part of the Slice of Healthcare podcast network:LinkedIn: https://www.linkedin.com/company/sliceofhealthcare/

Ver todos los episodios